Awareness of cytomegalovirus infection among pregnant women in Geneva, Switzerland: A cross-sectional study

International Journal of Environmental Research and Public Health

Volumn 12, Issue 12, 2015, Pages 15285-15297

  Willame, Alexia ^a   Blanchard Rohner, Geraldine ^a   Combescure, Christophe ^a   Irion, Olivier ^a   Posfay Barbe, Klara ^a   de Tejada, Begoña Martinez ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Awareness; Congenital; Cytomegalovirus; Infection; Information; Knowledge; Pregnancy

Indexed keywords

DISEASE INCIDENCE; DISEASE TREATMENT; HEALTH RISK; INFECTIVITY; INFORMATION SYSTEM; PREGNANCY; QUESTIONNAIRE SURVEY; VIRAL DISEASE; WOMENS HEALTH;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HEARING IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MENTAL DEFICIENCY; PREGNANCY; PREGNANCY OUTCOME; PUERPERIUM; RISK FACTOR; RUBELLA; SWITZERLAND; SYPHILIS; TOXOPLASMOSIS; ATTITUDE TO HEALTH; COMPLICATION; MIDDLE AGED; PREGNANCY COMPLICATION; QUESTIONNAIRE; TRANSMISSION; VERTICAL TRANSMISSION; YOUNG ADULT;

GENEVA [SWITZERLAND]; SWITZERLAND;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; STREPTOCOCCUS SP. 'GROUP B';

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SURVEYS AND QUESTIONNAIRES; SWITZERLAND; YOUNG ADULT;

EID: 84949203405     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph121214982     Document Type: Article

References (69)

1. Walker, S.; Palmo-Dias, R. Wood, E. M.; Shekleton, P. Giles, M. L. Cytomegalovirus in pregnancy: To screen or not to screen. BMC Pregnancy Childbirth 2013, 13, 96–104. [CrossRef] [PubMed]
2. Dollard, S.; Grosse, S.; Ross, D. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 2007, 17, 355–363. [CrossRef] [PubMed]
3. Boppana, S.; Fowler, K.; Britt, W.; Stagno, S.; Pass, R.F. Symptomatic congenital cyto-megalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999, 104, 55–60. [CrossRef] [PubMed]
4. Basha, J.; Iwasenko, J.M.; Robertson, P.; Craig, M.E.; Rawlinson, W. Congenital cytomegalovirus infection is associated with high maternal socio-economic status and corresponding low maternal cytomegalovirus seropositiviy. J. Paediatr. Child Health 2014, 50, 368–372. [CrossRef] [PubMed]
5. Kenneson, A.; Cannon, M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus infection. Rev. Med. Virol. 2007, 17, 253–276. [CrossRef] [PubMed]
6. Bate, S.; Dollard, S.; Cannon, M.J. Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988–2004. Clin. Infect. Dis. 2010, 50, 1439–1447. [CrossRef] [PubMed]
7. Yamamoto, A.; Mussi-Pinhata, M.M.; Boppana, S.B.; Novak, Z.; Wagatsuma, V.M.; de Oliveira, P.F.; Duarte, G.; Britt, W.J. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am. J. Obstet. Gynecol. 2010, 202, 297.e1–297.e8. [CrossRef] [PubMed]
8. Ornoy, A.; Diav-Citrin, O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod. Toxicol. 2006, 21, 399–409. [CrossRef] [PubMed]
9. Zalel, Y.; Gilboa, Y.; Berkenshtat, M.; Yoeli, R.; Auslander, R.; Achiron, R.; Goldberg, Y. Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet. Gynecol. 2008, 31, 417–420. [CrossRef] [PubMed]
10. Hui, L. Wood, G. Perinatal outcome after maternal primary cytomegalovirus infection in the first trimestre: A practical update and counseling aid. Prenat. Diagn. 2015, 35, 1–7. [CrossRef] [PubMed]
11. Nigro, G.; La Torre, R.; Anceschi, M.M.; Mazzocco, M.; Cosmi, E. Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am. J. Obstet. Gynecol. 1999, 180, 1222–1226. [CrossRef]
12. Adler, S.P.; Nigro, G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J. Clin. Virol. 2009, 46, 54–57. [CrossRef] [PubMed]
13. Nigro, G.; Adler, S.P.; la Torre, R. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 2005, 353, 1350–1362. [CrossRef] [PubMed]
14. Buxmann, H.; Stackelberg, O.M.; Schlößer, R.L.; Enders, G.; Gonser, M.; Meyer-Wittkopf, M.; Hamprecht, K.; Enders, M. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: A retrospective analysis. J. Perinatal. Med. 2012, 40, 439–446. [CrossRef] [PubMed]
15. Jückstock, J.; Rothenburger, M.; Friese, K.; Traunmüller, F. Passive immunization against congenital cytomegalovirus infection: Current state of knowledge. Pharmacology 2015, 95, 209–217. [CrossRef] [PubMed]
16. Visentin, S.; Manara, R.; Milanese, L.; da Roit, A.; Forner, G.; Salviato, E.; Citton, V.; Magno, F.M.; Orzan, E.; Morando, C. et al. Early primary cytomegalovirus infection in pregnancy: Maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin. Infect. Dis. 2012, 55, 497–503. [CrossRef] [PubMed]
17. Nigro, G.; Adler, S.P.; Mascaretti, G.; Megaloikonomou, A.; la Torre, R.; Necozione, S.; Gatta, E. Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy. J. Matern. Fetal Neonatal Med. 2012, 25, 2202–2205. [CrossRef] [PubMed]
18. Moxley, K.; Knudtson, E. J. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet. Gynecol. 2008, 111, 524–526. [CrossRef] [PubMed]
19. Moise, K.J.; Wolfe, H. Treatment of second trimester fetal cytomegalovirus infection with maternal hyperimmune globulin. Prenat. Diagn. 2008, 28, 264–265. [CrossRef] [PubMed]
20. Nigro, G.; Torre, R.; de Tejada, B.; Adler, S.P.; Lituania, M.; Pentimalli, H. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat. Diagn. 2008, 28, 512–517. [CrossRef] [PubMed]
21. Revello, M.G.; Gerna, G. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N. Engl. J. Med. 2014, 70, 1316–1326. [CrossRef] [PubMed]
22. Lombardi, G.; Garofoli, F.; Villani, P.; Tizzoni, M.; Angelini, A.; Cusato, M.; Bollani, L.; de Silvestri, A.; Regazzi, M.; Stronati, M. Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28, 1465–1470. [CrossRef] [PubMed]
23. Del Rosal, T.; Baquero-Artigao, F.; Blazquez, D.; Noguera-Julian, A.; Moreno-Pérez, D.; Reyes, A.; Vilas, J. Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period. J. Clin. Virol. 2012, 55, 72–74. [CrossRef] [PubMed]
24. Whitley, R.J.; Cloud, G.; Gruber, W. G.; Storch, G. Demmler, R. Jacobs, W. Dankner, S. Spector, S. Starr, R. Pass, S. et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study. J. Infect. Dis. 1997, 175, 1080–1086. [CrossRef] [PubMed]
25. Michaels, M.G.; Greenberg, D.P.; Sabo, D.L.; Wald, E.R. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr. Infect. Dis. J. 2003, 22, 504–509. [CrossRef] [PubMed]
26. Kimberlin, D.W.; Lin, C.Y.; Sanchez, P.J. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial. J. Pediatr. 2003, 143, 16–25. [CrossRef]
27. Tanaka-Kitajima, N.; Futatani, T.; Sugaya, N. Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr. Infect. Dis. J. 2005, 24, 782–785. [CrossRef] [PubMed]
28. Lackner, A.; Acham, A; Alborno, T. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: Four to 10 year follow up. J. Laryngol. Otol. 2009, 123, 391–396. [CrossRef] [PubMed]
29. Amir, J. Wolf, D. Levy, I. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by longterm oral valganciclovir. Eur. J. Pediatr. 2010, 169, 1061–1067. [CrossRef] [PubMed]
30. Ishida, Y.; Miyajima, T.; Shimura, M.; Morichi, S.; Morishima, Y.; Ioi, H.; Oana, S.; Yamanaka, G.; Kawashima, H.; Hoshika, A. Successful treatment of congenital cytomegalovirus infection with valganciclovir. No to Hattatsu 2012, 44, 55–59. [PubMed]
31. Dasari, V.; Smith, C.; Khanna, R. Recent advances in designing an effective vaccine to prevent cytomegalovirus associated clinical disease. Expert Rev. Vaccines 2013, 12, 661–676. [CrossRef] [PubMed]
32. Fu, T.; An, Z.; Wang, D. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease. Vaccine 2014, 32, 2525–2533. [CrossRef] [PubMed]
33. Griffiths, P.; Plotkin, S.; Mocarski, E.; Pass, R.; Schleiss, M.; Krause, P. Bialek, S. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013, 31, 197–203. [CrossRef] [PubMed]
34. Krause, P.; Bialek, S.R.; Boppana, S.B.; Griffiths, P.D.; Laughlin, C.A.; Ljungman, P.; Mocarski, E.S.; Pass, R.F.; Read, J.S.; Schleiss, M. R.; et al. Priorities for CMV vaccine development. Vaccine 2013, 32, 4–10. [CrossRef] [PubMed]
35. Rieder, F.; Steiniger, C. Cytomegalovirus vaccine: Phase II clinical trial results. Clin. Microbiol. Infect. 2014, 5, 95–102. [CrossRef] [PubMed]
36. Plotkin, S. The history of vaccination against cytomegalovirus. Med. Microbiol. Immunol. 2015, 204, 247–254. [CrossRef] [PubMed]
37. Cahill, A.G.; Odibo, A.O.; Stamilio, D.M.; Macones, G.A. Screening and treating for primary cytomegalovirus infection in pregnancy: Where do we stand? A decision-analytic and economic analysis. Am. J. Obstet. Gynecol. 2007, 201, 466.e1–466.e7. [CrossRef] [PubMed]
38. Carslson, A.; Norwitz, E.; Stiller, R.J. Cytomegalovirus infection in pregnancy: Should all women be screened? Rev. Obstet. Gynecol. 2010, 3, 172–179.
39. Adler, S.; Finney, J.W.; Manganello, A.M.; Best, A.M. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial. Pediatr. Infect. Dis. 1996, 15, 240–246. [CrossRef]
40. Picone, O.; Vauloup-Fellous, C.; Cordier, A.G.; Parent-du-Châtelet, I.; Senat, M.-V.; Frydman, R.; Grangeot-Keros, L. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 2009, 116, 818–823. [CrossRef] [PubMed]
41. Vauloup-Felloup, C.; Picone, O.; Cordier, A.G.; Parent-du-Châtelet, I.; Senat, M.-V.; Frydman, R.; Grangeot-Keros, L. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J. Clin. Virol. 2009, 46 (Suppl. 4), S49–S53. [CrossRef] [PubMed]
42. Harvey, J.; Dennis, C. Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: Systematic review. J. Adv. Nurs. 2008, 63, 440–450. [CrossRef] [PubMed]
43. Cordier, A.; Vauloup-Fellous, C.; Picone, O. Is maternal infection with cytomegalovirus prevention possible? Gynecol. Obstet. Fertil. J. 2010, 38, 620–623. [CrossRef] [PubMed]
44. Centers for Disease Prevention and Control. Clinical Diagnosis and Treatment, Cytomegalovirus; CDC: Atlanta, GA, USA, 2010. Available online: http://www.cdc.gov/cmv/clinical/diagnosis-treatment.html (accessed on 10 June 2015).
45. Hyde, T.B.; Schmid, D.S.; Cannon, M.J. CMV seroconversion rates and risks factors: Implication for congenital CMV. Rev. Med. Virol. 2010, 20, 311–326. [CrossRef] [PubMed]
46. Cannon, M.J. Congenital cytomegalovirus epidemiology awareness. J. Clin. Virol. 2009, 46, 6–10. [CrossRef] [PubMed]
47. Pereboom, M.; Manniën, J.; Spelten, E.R.; Schellevis, F.G.; Hutton, E.K. Observational study to assess pregnant women’s knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus. BMC Pregnancy Childbirth 2013. [CrossRef] [PubMed]
48. Cannon, M.J.; Davis, K. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005. [CrossRef] [PubMed]
49. Ross, D.; Victor, M.; Sumartojo, E.; Cannon, M.J. Women’s knowledge of congenital cytomegalovirus. J. Womens Health 2008, 17, 849–858. [CrossRef] [PubMed]
50. Anderson, B.; Schulkin, J.; Ross, D. Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy. CDC Morb. Mortal. Wkly. Rep. 2008, 57, 65–68.
51. Cordier, A.; Guitton, S.; Vauloup-Fellous, C.; Grangeot-Keros, L.; Benachi, A.; Picone, O. Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France. J. Clin. Virol. 2012, 55, 158–163. [CrossRef] [PubMed]
52. Korver, A.; de Vries, J.J.; de Jong, J.W.; Dekker, F.W.; Vossen, A.C.; Oudesluys-Murphy, A. Awareness of congenital cytomegalovirus among doctors in the Netherlands. J. Clin. Virol. 2009, 46, 11–15. [CrossRef] [PubMed]
53. Cordier, A.; Guitton, S.; Vauloup-Fellous, C.; Grangeot-Keros, L.; Benachi, A.; Picone, O. Awareness of cytomegalovirus infection among pregnant women in France. J. Clin. Virol. 2012, 53, 332–337. [CrossRef] [PubMed]
54. Jeon, J.; Victor, M.; Adler, S.P.; Arwady, A.; Demmler, G.; Fowler, K.; Goldfarb, J.; Keyserling, H.; Massoudi, M.; Richard, K.; Staras, S.A.; Cannon, M.J. Knowledge and awareness of congenital cytomegalovirus among women. Infect. Dis. Obstet. Gynecol. 2006. [CrossRef] [PubMed]
55. Lim, S.; Tan, W.C.; Tan, L.K. Awareness of and attitudes toward congenital cytomegalovirus infection among pregnant women in Singapore. Int. J. Obstet. Gynecol. 2011, 117, 268–272. [CrossRef] [PubMed]
56. Morioka, I.; Sonoyama, A.; Tairaku, S.; Ebina, Y.; Nagamata, S.; Morizane, M.; Tanimura, K.; Iijima, K.; Yamada, H. Awareness of and knowledge about mother-to-child infections in Japanese pregnant women. Congenit. Anomal. 2014, 54, 35–40. [CrossRef] [PubMed]
57. Swiss Federal Office of Public Health. Naissances en Suisse; Swiss Federal Office of Public Health: Berne, Switzerland, 2013; Available online: http://www.bag.admin.ch/themen/medizin/13641/index.html?lang=fr (accessed on 29 April 2015).
58. Swiss Federal Office of Public Health. VIH et autres infections sexuellement transmissibles. Swiss Federal Office of Public Health: Berne, Switzerland, 2010; Available online: http://www.hiv.ch/rubriken/epidx/ bag/BAG_2f_HIV_Programm_lang.pdf(accessed on 29 April 2015).
59. Vaudaux, B.; Kind, C. Prise en charge de la toxoplasmose chez l’enfant. Paediatrica 2010, 21, 66–69.
60. Jones, J.L.; Krueger, A.; Schulkin, J.; Schantz, P.M. Toxoplasmosis prevention and testing in pregnancy. Survey of obstetricians and gynaecologists. Zoonose Public Health 2010, 57, 27–33. [CrossRef] [PubMed]
61. Kahn, J.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: A model. PLoS ONE 2014. [CrossRef] [PubMed]
62. Meyer, P.; Meyer Sauteur, P.M.; Trück, J.; Bosshard, P.P.; Tomaske, M.; Cadenas, M.F.; Lautenschlager, S.; Goetschel, P. Congenital syphilis in Switzerland: Gone, forgotten, on the return. Swiss Med. Wkly. 2012. [CrossRef]
63. Newman, L.M.; Kamb, M.; Hawkes, S.; Gomez, G.; Say, L.; Seuc, A.; Broutet, N. Global estimates of syphilis in pregnancy and associated adverse outcomes: Analysis of multinational antenatal surveillance data. PLOS Med. 2013. [CrossRef] [PubMed]
64. Centers for Disease Control and Prevention. STD Surveillance-Syphilis. 2011. Available online: http://www.cdc.gov/std/stats11/syphilis.htm (accessed on 3 June 2015).
65. Robert-Gangneux, F.; Dardé, M.-L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 2012, 25, 264–296. [CrossRef] [PubMed]
66. Bénard, A.; Petersen, E.; Salamon, R.; Chêne, G.; Gilbert, R.; Rachid Salmi, L.; European Toxo Prevention Study Group. Survey of European programmes for the epidemiological surveillance of congenital toxoplasomosis. Euro. Surveill. 2008,13. Available online: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2740836 (accessed on 3 June 2015).
67. Vaudaux, B.; Rudin, C. Abandon du dépistage de la toxoplasmose durant la grossesse. Une brève explication. Forum Med. Suisse 2009, 9, 105–106.
68. Revello, M.G.; Tibaldi, C.; Masuelli, G.; Frisina, V.; Sacchi, A.; Furione, M.; Arossa, A.; Spinillo, A.; Klersy, C.; Ceccarelli, M. et al. Prevention of Primary Cytomegalovirus Infection in Pregnancy. EBio Med. 2015, 2, 1205–1210. [CrossRef] [PubMed]
69. Rudin, C.; Boubaker, K.; Raeber, P.A.; Vaudaux, B.; Bucher, H.C.; Garweg, J.G.; Hoesli, I.; Kind, C.; Hohlfeld, P. Toxoplasmosis during pregnancy and infancy A new approach for Switzerland. Swiss Med. Wkly. 2008, 138, 1–8